Business Context and Reporting Period
This Form 8-K filing by Altimmune, Inc. is dated May 17, 2018. The report addresses a regulatory notification received from The Nasdaq Stock Market LLC regarding the continued listing status of the Company's common stock.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the listing review: the bid price of the Common Stock closed below the minimum $1.00 per share requirement for 30 consecutive business days.
Material Changes
The material change reported is the receipt of a notice from Nasdaq indicating potential delisting due to failure to meet the minimum bid price requirement under Marketplace Rule 5550(a)(2). This notice has no immediate effect on the listing or trading of the stock.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial 180-calendar-day period, ending November 13, 2018, to regain compliance.
- Regaining Compliance: Compliance is achieved if the bid price closes at $1.00 or more for 10 consecutive business days before the deadline.
- Secondary Options: If compliance is not met by November 13, 2018, the Company may be eligible for an additional 180-day period. This requires meeting the market value of publicly held shares requirement and all other initial listing standards, potentially necessitating a reverse stock split.
- Delisting Risk: Failure to qualify for or succeed in the second compliance period will result in a determination to delist the stock, at which point the Company may appeal to a Hearings Panel.
- Management Action: Management intends to monitor the closing bid price and may consider implementing available options, such as a reverse stock split, to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of Altimmune, Inc. common stock relative to the $1.00 threshold.
- Monitor the stock price for 10 consecutive business days to determine if the initial compliance period is satisfied.
- Review the Company's market value of publicly held shares to assess eligibility for a second compliance period if the initial deadline is missed.
- Watch for future announcements regarding the potential implementation of a reverse stock split.